Skip to main content
BMC Cardiovascular Disorders logoLink to BMC Cardiovascular Disorders
. 2021 Feb 15;21:91. doi: 10.1186/s12872-021-01873-2

Correction to: Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study

M Unverdorben 1,, C von Heymann 2, A Santamaria 3, M Saxena 4, T Vanassche 5, J Jin 1, P Laeis 6, R Wilkins 7, C Chen 1, P Colonna 8
PMCID: PMC7885390  PMID: 33588744

Correction to: BMC Cardiovasc Disord (2020) 20:504 10.1186/s12872-020-01766-w

After publication of the original article [1], the authors identified an error in Table 1 related to two values on EHRA bleeding risk-low row.

The correct values are listed below:

EHRA bleeding risk-low n, (%)

174

(62.1)

580

(49.9)

457

(55.1)

297

(48.5)

283

(51.5)

252

(49.0)

45

(45.9)

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Unverdorben M, et al. Elderly patients with atrial fibrillation in routine clinical practice: peri-procedural management of edoxaban oral anticoagulation therapy is associated with a low risk of bleeding and thromboembolic complications: a subset analysis of the prospective, observational, multinational EMIT-AF study. BMC Cardiovasc Disord. 2020;20:504. doi: 10.1186/s12872-020-01766-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cardiovascular Disorders are provided here courtesy of BMC

RESOURCES